Editorial: Women in renal pharmacology: 2021

Bibliographic Details
Main Authors: Ariela Benigni, Susanna Tomasoni
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1054354/full
_version_ 1797990425523388416
author Ariela Benigni
Susanna Tomasoni
author_facet Ariela Benigni
Susanna Tomasoni
author_sort Ariela Benigni
collection DOAJ
first_indexed 2024-04-11T08:36:19Z
format Article
id doaj.art-19cdd07835ff47979db69c3044c0ca02
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T08:36:19Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-19cdd07835ff47979db69c3044c0ca022022-12-22T04:34:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-10-011310.3389/fphar.2022.10543541054354Editorial: Women in renal pharmacology: 2021Ariela BenigniSusanna Tomasonihttps://www.frontiersin.org/articles/10.3389/fphar.2022.1054354/fullsexchronic kidney diseasediabetic nephropathyangiotensin II receptor blockerreceptor tyrosine kinases
spellingShingle Ariela Benigni
Susanna Tomasoni
Editorial: Women in renal pharmacology: 2021
Frontiers in Pharmacology
sex
chronic kidney disease
diabetic nephropathy
angiotensin II receptor blocker
receptor tyrosine kinases
title Editorial: Women in renal pharmacology: 2021
title_full Editorial: Women in renal pharmacology: 2021
title_fullStr Editorial: Women in renal pharmacology: 2021
title_full_unstemmed Editorial: Women in renal pharmacology: 2021
title_short Editorial: Women in renal pharmacology: 2021
title_sort editorial women in renal pharmacology 2021
topic sex
chronic kidney disease
diabetic nephropathy
angiotensin II receptor blocker
receptor tyrosine kinases
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1054354/full
work_keys_str_mv AT arielabenigni editorialwomeninrenalpharmacology2021
AT susannatomasoni editorialwomeninrenalpharmacology2021